Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Bapcor is back in focus after analysts lifted the fair value estimate from A$0.59 to A$0.70, signalling a recalibration of what the stock might be worth under updated assumptions. The shift in the price target reflects recent research that balances a more constructive view on valuation with ongoing caution about execution and external risks. As you read on, you will see how these changes fit into the evolving Bapcor story and what to watch as the narrative develops. Analyst Price Targets...
Bapcor Ltd (ASX:BAP) reports a statutory loss due to impairments, but strong working capital management and returning trade growth signal a successful turnaround.
Bapcor’s latest update comes with no change to the current price target, which keeps the existing valuation view firmly in place for now. With no fresh analyst commentary shaping that stance, the market is working off an unchanged formal outlook. As you read on, you will see how to track updates like this and what to watch to stay across Bapcor’s evolving investment narrative. Stay updated as the Fair Value for Bapcor shifts by adding it to your watchlist or portfolio. Alternatively, explore...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.